Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

Seligson & Co Global Top 25 Pharmac.

+ Add to Watchlist

SEL25PA:FH

27.65 EUR 0.000.00%

As of 01:59:30 ET on 05/05/2015.

Snapshot for Seligson & Co Global Top 25 Pharmac. (SEL25PA)

Year To Date: +19.35% 3-Month: +8.60% 3-Year: +30.40% 52-Week Range: 18.59 - 29.25
1-Month: -0.64% 1-Year: +47.17% 5-Year: +23.25% Beta vs HEXP: 0.69

Mutual Fund Chart for SEL25PA

No chart data available.
  • SEL25PA:FH 27.65
  • 1M
  • 1Y
Interactive SEL25PA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SEL25PA

Seligson & Co Global Top 25 Pharmaceuticals is an open-end fund incorporated in Finland. The Fund's objective is a return that follows the return of the world's top 25 pharmaceutical companies. The Fund invests in a basket of equities of the world's top 25 pharmaceutical companies.

Inception Date: 01-15-2000 Telephone: 358-9-6817-8200
Managers: JANI HOLMBERG / JAANA TIMONEN
Web Site: www.seligson.fi

Fundamentals for SEL25PA

NAV (on 2015-05-05) 27.65
Assets (M) (on 2015-03-31) 233.67
Fund Leveraged N
Minimum Investment 1.00
Minimum Subsequent Investment 1.00

Dividends for SEL25PA

No dividends reported

Fees & Expenses for SEL25PA

Front Load 0.00
Back Load 0.50
Current Mgmt Fee 0.50
Redemption Fee 0.50
12b1 Fee 0.00
Expense Ratio 0.60

Top Fund Holdings for SEL25PA

Filing Date: 03/31/2015
Name Position Value % of Total
Pfizer Inc 475,549 15,485,974 6.627%
Novartis AG 162,817 15,269,347 6.535%
Roche Holding AG 55,851 14,426,733 6.174%
Johnson & Johnson 149,055 14,076,415 6.024%
Merck & Co Inc 250,154 13,574,537 5.809%
Biogen Inc 22,390 8,988,905 3.847%
Novo Nordisk A/S 177,331 8,956,879 3.833%
Merck KGaA 79,064 8,451,942 3.617%
Daiichi Sankyo Co Ltd 572,400 8,447,352 3.615%
Takeda Pharmaceutical Co Ltd 178,800 8,300,737 3.552%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil